Effects of some hypocholesterolemic agents on hepatic ulrastructure and microbody enzymes.
D000594:Amino Acid Oxidoreductases / Q000378:metabolism*; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001562:Benzimidazoles / Q000494:pharmacology; D001835:Body Weight; D002374:Catalase / Q000378:metabolism*; D002784:Cholesterol / Q000097:blood; D006220:Haloperidol / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D050356:Lipid Metabolism; D008099:Liver / Q000166:cytology* / Q000187:drug effects; D008297:Male; D008830:Microbodies / Q000187:drug effects / Q000201:enzymology; D008854:Microscopy, Electron; D009929:Organ Size; D009940:Organoids / Q000201:enzymology*; D010088:Oxidoreductases / Q000378:metabolism*; D010879:Piperazines / Q000494:pharmacology; D051381:Rats
D000924:Anticholesteremic Agents; D001562:Benzimidazoles; D006634:Histamine H1 Antagonists; D010879:Piperazines; D002784:Cholesterol; D010088:Oxidoreductases; D002374:Catalase; D000594:Amino Acid Oxidoreductases; D006220:Haloperidol